全球医生办公室诊断市场

预计到 2030 年全球医师办公室诊断市场规模将达到 2.365 亿美元

全球医师诊间诊断市场规模预计在2024年为1.159亿美元，到2030年将达到2.365亿美元，在2024-2030年的分析期间内，复合年增长率为12.6%。即时检验设备是本报告分析的细分市场之一，预计其复合年增长率为14.6%，到分析期结束时规模将达到1.141亿美元。临床化学分析仪细分市场在分析期间的复合年增长率预计为10.1%。

美国市场规模估计为 3,160 万美元，中国市场预计复合年增长率为 17.3%

美国医师诊间诊断市场规模预计在2024年达到3,160万美元。作为世界第二大经济体，中国预计在2030年达到5,060万美元的市场规模，2024年至2030年的复合年增长率为17.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为9.0%和11.4%。在欧洲，预计德国的复合年增长率为10.0%。

全球医生办公室诊断市场—主要趋势和驱动因素摘要

为什么诊所诊断正在成为医疗服务提供者和患者的热门选择？

医生诊室诊断涵盖常规就诊期间进行的各种检测，以便及时做出诊断和治疗决策。这些检测包括血液和尿液检查检测、心电图、影像学检查、快速抗原检测以及照护现场分析仪。便捷的现场诊断可提高临床效率、患者依从性并缩短诊断週期。

医生也越来越多地投资于糖尿病、呼吸道感染疾病、心血管疾病、性行为感染等诊断工具。这些工具有助于减少患者到诊所就诊和后续预约的需求，这在初级保健和紧急护理机构中尤其重要。即时提供结果可以提高患者满意度，并实现当日治疗。

诊断技术如何发展以支持初级保健环境？

现代诊所诊断着重紧凑易用的仪器，这些仪器能够以最少的样本製备提供准确的结果。目前，POC 检测平台包括专为小型诊所设计的免疫检测、分子诊断和数位影像工具。为了简化工作流程并确保符合文件标准，人们正在采用具有无线连接的自动化分析仪。

穿戴式诊断设备和可携式超音波仪器也被引入初级保健机构，从而扩大了检测能力。云端连接诊断平台促进了数据与电子健康记录(EHR) 的集成，从而提高了护理的连续性和人群健康追踪。横向流动技术、微流体和多重检测的进步进一步提高了诊断速度和准确性。

采用范围在哪些地方扩大以及哪些测试类别最为活跃？

医师诊间诊断广泛应用于家庭医学、内科、小儿科及急诊医学。支持慢性病管理、感染疾病检测和心血管风险监测的检测需求尤其强劲。这些检测包括糖化血红蛋白 (HbA1c)、血脂组、链球菌检测、流感和新冠肺炎 (COVID-19) 检测、尿液检查、心电图等等。

北美凭藉其先进的初级保健基础设施和报销支援仍然是最大的市场，但随着初级保健系统不断扩大，欧洲和亚太地区的采用率也在不断增长。政府改善预防性筛检和慢性病管理的措施也在推动办公室护理环境中的诊断可近性。

医生办公室诊断市场的成长受到多种因素的推动。

医生诊室诊断市场的成长动力源于对即时诊断检测日益增长的需求、慢性病的日益流行以及微型照护现场技术的进步。自动化分析仪的广泛应用、与电子医疗系统的整合以及针对特定疾病的快速检测的扩展，共同推动了这一增长。

此外，医生们正在投资诊断技术，以提高执业效率、减少患者候诊时间并改善护理协调。支持预防性筛检和慢性病监测的报销框架正在增强市场稳定性。随着患者数量的增加和对即时护理的期望值不断提高，都市区医疗机构对诊室内诊断的需求将持续增长。

部分

产品类型（就地检验设备、临床化学分析仪、免疫检测系统、分子诊断设备、尿液检查系统）；应用（感染疾病应用、心血管疾病应用、代谢疾病应用、癌症诊断应用、怀孕应用、不孕症检测应用）

受访公司范例

• Abbott Laboratories
• Alere Inc.（Now Abbott）
• BD（Becton, Dickinson and Co.）
• Bio-Rad Laboratories
• Bio-Techne Corporation
• Cepheid
• EKF Diagnostics
• F. Hoffmann-La Roche Ltd
• HemoCue AB
• HORIBA Medical
• Labcorp
• Nova Biomedical
• Ortho Clinical Diagnostics
• QuidelOrtho Corporation
• Radiometer Medical
• Randox Laboratories
• Sekisui Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Physician Office Diagnostics Market to Reach US$236.5 Million by 2030

The global market for Physician Office Diagnostics estimated at US$115.9 Million in the year 2024, is expected to reach US$236.5 Million by 2030, growing at a CAGR of 12.6% over the analysis period 2024-2030. Point-of-Care Testing Devices, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$114.1 Million by the end of the analysis period. Growth in the Clinical Chemistry Analyzers segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.6 Million While China is Forecast to Grow at 17.3% CAGR

The Physician Office Diagnostics market in the U.S. is estimated at US$31.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$50.6 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.0% and 11.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.0% CAGR.

Global Physician Office Diagnostics Market - Key Trends & Drivers Summarized

Why Are In-Office Diagnostics Gaining Preference Among Providers and Patients?

Physician office diagnostics encompass a wide range of tests conducted during a routine visit, allowing timely diagnosis and treatment decisions. These include blood tests, urinalysis, ECGs, imaging, rapid antigen tests, and point-of-care analyzers. The convenience of conducting diagnostics on-site improves clinical efficiency, patient compliance, and diagnostic turnaround times.

Physicians are increasingly investing in diagnostic tools for conditions such as diabetes, respiratory infections, cardiovascular disease, and sexually transmitted infections. These tools help reduce the need for external lab visits and follow-up appointments, particularly important in primary care and urgent care settings. The ability to deliver immediate results enhances patient satisfaction and enables same-day treatment initiation.

How Are Diagnostic Technologies Evolving to Support Primary Care Settings?

Modern physician office diagnostics focus on compact, user-friendly devices that offer accurate results with minimal sample preparation. Point-of-care testing platforms now include immunoassays, molecular diagnostics, and digital imaging tools designed for small practice environments. Automated analyzers with wireless connectivity are being adopted to streamline workflow and ensure compliance with documentation standards.

Wearable diagnostics and portable ultrasound devices are also entering primary care practices, enabling expanded examination capabilities. Cloud-connected diagnostic platforms facilitate data integration with electronic health records (EHRs), improving continuity of care and population health tracking. Advances in lateral flow technology, microfluidics, and multiplex testing are further enhancing diagnostic speed and precision.

Where Is Adoption Expanding and Which Test Categories Are Most Active?

Physician office diagnostics are widely used across family medicine, internal medicine, pediatrics, and urgent care. Demand is particularly high for tests that support chronic disease management, infectious disease detection, and cardiovascular risk monitoring. These include HbA1c, lipid panels, strep tests, flu and COVID-19 testing, urinalysis, and ECGs.

North America remains the largest market due to advanced primary care infrastructure and reimbursement support. However, adoption is growing in Europe and Asia-Pacific, where primary care systems are expanding. Government initiatives to improve preventive screening and chronic disease management are also promoting diagnostic access in office-based care environments.

Growth in the Physician Office Diagnostics market is driven by several factors…

Growth in the physician office diagnostics market is driven by the rising demand for rapid, in-practice diagnostic testing, increasing prevalence of chronic diseases, and advances in compact, point-of-care technologies. Broader use of automated analyzers, integration with electronic health systems, and expansion of disease-specific rapid tests are supporting adoption.

Physicians are also investing in diagnostics to enhance practice efficiency, reduce patient wait times, and improve care coordination. Reimbursement frameworks that support preventive screenings and chronic condition monitoring are strengthening market stability. As patient volume grows and expectations for immediate care rise, demand for in-office diagnostics is set to continue increasing across urban and rural care settings.

SCOPE OF STUDY:

The report analyzes the Physician Office Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, Urinalysis Systems); Application (Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application, Cancer Diagnosis Application, Pregnancy Application, Fertility Testing Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• Abbott Laboratories
• Alere Inc. (Now Abbott)
• BD (Becton, Dickinson and Co.)
• Bio-Rad Laboratories
• Bio-Techne Corporation
• Cepheid
• EKF Diagnostics
• F. Hoffmann-La Roche Ltd
• HemoCue AB
• HORIBA Medical
• Labcorp
• Nova Biomedical
• Ortho Clinical Diagnostics
• QuidelOrtho Corporation
• Radiometer Medical
• Randox Laboratories
• Sekisui Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Physician Office Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Rapid and On-the-Spot Test Results Propels Growth in Physician Office Diagnostics
  • Shift Toward Decentralized Healthcare Delivery Expands the Role of In-Office Diagnostic Testing
  • Point-of-Care Technology Advancements Strengthen the Business Case for Diagnostic Equipment in Primary Care
  • Increasing Chronic Disease Burden Fuels Demand for Routine Testing and Real-Time Monitoring in Clinics
  • Patient Preference for Convenience and Faster Diagnosis Drives Adoption of In-Office Testing Solutions
  • Integration with Electronic Health Records (EHR) Enhances Workflow Efficiency and Diagnostic Accuracy
  • Growth in Preventive and Personalized Medicine Supports Expansion of Multi-Panel Diagnostic Tools
  • Cost Pressures and Value-Based Care Models Propel Use of In-House Diagnostics to Reduce Referrals and Delays
  • Miniaturization and Connectivity in Diagnostic Devices Enable Broader Use in Smaller Physician Practices
  • Expansion of Diagnostic Capabilities in Family and Internal Medicine Clinics Sustains Market Growth
  • Training and Ease-of-Use Improvements Drive Wider Adoption Among Non-Specialist Healthcare Providers
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Physician Office Diagnostics Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Physician Office Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Point-of-Care Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Point-of-Care Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Point-of-Care Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Clinical Chemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Clinical Chemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Immunoassay Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Urinalysis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Urinalysis Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Urinalysis Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pregnancy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pregnancy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Pregnancy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Fertility Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Fertility Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiovascular Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Cardiovascular Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Metabolic Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Metabolic Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Metabolic Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cancer Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cancer Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Cancer Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• JAPAN
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• CHINA
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• EUROPE
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Physician Office Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• FRANCE
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 71: France Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: France Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 73: France 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 74: France Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• GERMANY
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 77: Germany Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Germany Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 79: Germany 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 80: Germany Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Germany Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 82: Germany 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 83: Italy Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Italy Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 85: Italy 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 86: Italy Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Italy Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 88: Italy 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 89: UK Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: UK Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 91: UK 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 92: UK Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: UK Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 94: UK 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 95: Spain Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Spain Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 97: Spain 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 98: Spain Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Spain Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 100: Spain 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 101: Russia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Russia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 103: Russia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 104: Russia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Russia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 106: Russia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Rest of Europe Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 109: Rest of Europe 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Rest of Europe Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 112: Rest of Europe 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 114: Asia-Pacific Historic Review for Physician Office Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 115: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Asia-Pacific Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 118: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 122: Australia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Australia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 124: Australia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 125: Australia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Australia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 127: Australia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• INDIA
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 128: India Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: India Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 130: India 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 131: India Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: India Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 133: India 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 134: South Korea Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: South Korea Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 136: South Korea 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 137: South Korea Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: South Korea Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 139: South Korea 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Asia-Pacific Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Asia-Pacific Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 146: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 147: Latin America Historic Review for Physician Office Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 148: Latin America 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 149: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Latin America Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 151: Latin America 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 152: Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Latin America Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 154: Latin America 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 155: Argentina Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Argentina Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 157: Argentina 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 158: Argentina Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Argentina Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 160: Argentina 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 161: Brazil Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Brazil Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 163: Brazil 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 164: Brazil Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Brazil Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 166: Brazil 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 167: Mexico Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Mexico Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 169: Mexico 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 170: Mexico Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Mexico Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 172: Mexico 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Latin America Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 175: Rest of Latin America 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Latin America Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Latin America 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 179: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 180: Middle East Historic Review for Physician Office Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 181: Middle East 16-Year Perspective for Physician Office Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 182: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Middle East Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 184: Middle East 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 185: Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Middle East Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 187: Middle East 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 188: Iran Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Iran Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 190: Iran 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 191: Iran Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Iran Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 193: Iran 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 194: Israel Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Israel Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 196: Israel 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 197: Israel Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Israel Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 199: Israel 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Saudi Arabia Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 202: Saudi Arabia 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Saudi Arabia Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 205: Saudi Arabia 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 206: UAE Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: UAE Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 208: UAE 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 209: UAE Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: UAE Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 211: UAE 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Middle East Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 214: Rest of Middle East 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Rest of Middle East Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 217: Rest of Middle East 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030
• AFRICA
  • Physician Office Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 218: Africa Recent Past, Current & Future Analysis for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Africa Historic Review for Physician Office Diagnostics by Product Type - Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 220: Africa 16-Year Perspective for Physician Office Diagnostics by Product Type - Percentage Breakdown of Value Sales for Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics and Urinalysis Systems for the Years 2014, 2025 & 2030
  • TABLE 221: Africa Recent Past, Current & Future Analysis for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Africa Historic Review for Physician Office Diagnostics by Application - Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
  • TABLE 223: Africa 16-Year Perspective for Physician Office Diagnostics by Application - Percentage Breakdown of Value Sales for Pregnancy Application, Fertility Testing Application, Infectious Diseases Application, Cardiovascular Disorders Application, Metabolic Disorders Application and Cancer Diagnosis Application for the Years 2014, 2025 & 2030

IV. COMPETITION